TOP NEWS: Hot start: First Volunteer receives Curevac vaccine

The Covid-19-pandemic keeps the world in breath. More than 8.5 million people have been infected so far worldwide, with the novel Coronavirus, 187.942 in Germany – where it always comes back to local outbreaks. All the News on the Corona-crisis in Germany, Europe and the world read in the News-Ticker of FOCUS Online.

TOP NEWS: Hot start: First Volunteer receives Curevac vaccine

15.41 PM: The study of the Corona vaccine the company Curevac is on Friday in the hot Phase is gone: A Volunteer received at the University hospital of Tübingen, the first vaccination. Then the young Person to stay 24 hours under observation – it will be monitored both in the Monitor as well as Doctors, said study leader Peter Kremsner of the German press Agency. "In the case of Children is, to date, never happened something Serious, but we want to make sure." Kremsner is expecting in two months, with the first results. "This is quite a fix gehen", the Director of the Institute for tropical medicine said, where the active ingredient is tested. dpa/Sebastian Gollnow/dpa the objective of the first Phase of the study, was it, something about the compatibility and the immune protection to know, say the experts.

Already, reports have discovered because of the media hundreds of Volunteers. As soon as a letter is written with a call, it’ll probably be thousands of applications. For the University hospital of Tübingen, it was a home game. For the study, 100 healthy participants between the ages of 18 and 60 years of age will be required. "If all goes well with the first Subject, come Monday, the next three on Wednesday, then four to eight and from then on always mehr", Kremsner said. You all would be observed in the connection, in the further course of the vaccination will increase the dose or even a second vaccination administered, if the first will be well tolerated.

The goal of the first Phase of the study was to learn about the compatibility and the immune system. The tübingen-based company Curevac is working on so-called mRNA-vaccines. mRNA is a type of messenger molecule, in which the Instructions for the production of proteins is. For your vaccine Curevac have provided researchers mRNA with the Instruction for a Protein of the Coronavirus Sars-CoV-2. The human cells after vaccination of this Protein, which the body recognizes as foreign. He, however, makes antibodies and other immune cells.

 

Merkel is the AfD in the Bundestag with the one-liners emergence and garners loud applause

FOCUS Online/Wochit Merkel has AfD in the Bundestag with one-liners emergence and garners loud applause  

All the important messages to the Coronavirus in the FOCUS Online Newsletter. Subscribe now.